Specific immunotherapy by the sublingual route for respiratory allergy. - Wikidata - awgldk - TriplyDB

Specific immunotherapy by the sublingual route for respiratory allergy.

Specific immunotherapy by the sublingual route for respiratory allergy.

http://www.wikidata.org/entity/Q34353492

about

Therapeutic effects and biomarkers in sublingual immunotherapy: a review.The cost-effectiveness of immunotherapy for respiratory allergy: a review.Omalizumab for treatment of allergic rhinitis.The SQ House Dust Mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease.EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.Cutaneous vaccination with coated microneedles prevents development of airway allergy.

P2860

Q38002411-1AF16FF0-64B1-407A-9328-03DD83DD8348 Q38024158-9514D9C0-D5C7-4C69-91B4-13A61C2B82FC Q38101972-852AEB2C-4B58-4788-80B6-D9E179FD1913 Q47761576-D2E0CF9A-9AB5-48B9-8A57-06BDC08B2F43 Q47764778-CEDC133B-FB73-4240-BB46-585F95F5ED63 Q47778162-9B44036C-99BE-488D-ACEC-CF20FC455F1C

P2860

Specific immunotherapy by the sublingual route for respiratory allergy.

http://www.wikidata.org/entity/Q34353492

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Specific immunotherapy by the sublingual route for respiratory allergy.

@ast

Specific immunotherapy by the sublingual route for respiratory allergy.

@en

Specific immunotherapy by the sublingual route for respiratory allergy.

@nl

type

label

Specific immunotherapy by the sublingual route for respiratory allergy.

@ast

Specific immunotherapy by the sublingual route for respiratory allergy.

@en

Specific immunotherapy by the sublingual route for respiratory allergy.

@nl

prefLabel

Specific immunotherapy by the sublingual route for respiratory allergy.

@ast

Specific immunotherapy by the sublingual route for respiratory allergy.

@en

Specific immunotherapy by the sublingual route for respiratory allergy.

@nl

P1433

Q34353492-2DD04DFF-1235-4BA8-95EA-B3DEF960A39E

P1476

Q34353492-5314AC74-C38D-4071-8A31-B883648768E8

P2093

Q34353492-5B4F0BD2-80BD-435D-BF17-0B409D72F964

Q34353492-750E26AC-741A-44FA-AB6A-27AE09AEAC30

Q34353492-85C8BF75-C3E0-4860-8005-9B62B48C9720

Q34353492-E9CCA694-0F39-4B62-AC2E-C57E223FD9FB

P2860

Q34353492-06BCDAE1-D144-4C2C-B048-E63933E258D1

Q34353492-12847666-5C25-4CD4-A468-C5C97A5DF8AB

Q34353492-210B6CFD-520D-41DD-9B1E-FEB0FB42A272

Q34353492-2C578BDF-90BA-4162-AFBC-D21D696AEAF0

Q34353492-2DB49BFA-D3C6-40A3-B95F-478E2F1BF29A

Q34353492-30BB2A42-9395-48FF-8BF0-27D713F79BB2

Q34353492-323032AC-AD51-4E85-AACE-70DDA6388AC7

Q34353492-3880855A-74CB-43DA-85B0-A2103CCF1D6D

Q34353492-42A95CDB-0F32-40BD-9B75-D8C4BD9BD41F

Q34353492-51088972-9366-4F69-8C51-5FA83E5F7BB5

P2888

Q34353492-3C57E4AF-3190-4019-B2A1-8652177419D8

P304

Q34353492-1C2F95AF-87DC-479F-902F-6ECCFA5D9150

P31

Q34353492-833F76C8-58AC-405B-A25C-E831C16A004A

P356

Q34353492-15F8BCF7-3FCB-4867-94C4-84501CCCC4A0

P433

Q34353492-EBCF3E79-4BDF-4A4A-A612-2E3E75EF56DC

P478

Q34353492-D821F796-7F7C-4D70-8D31-99E7783E35EC

P50

Q34353492-536E38BB-C0AE-4378-83B0-1BB16FAE566C

P577

Q34353492-9CA96787-A2C0-463A-A263-1520E7103034

P5875

Q34353492-C6D334B8-1BC2-4D2D-A990-73EA720A0A56

P6179

Q34353492-B7F540E0-046B-4D3E-A2D3-F986F5158B74

P698

Q34353492-5F08E7D7-FB15-472D-9DDD-CF5B900F38EB

P921

Q34353492-F2BE9246-4759-4939-A525-325E49AB8EC3

P932

Q34353492-4505531E-E40C-449E-BC42-7183DF58E34B

P356

P1433

Allergy, Asthma & Clinical Immunology

P1476

Specific immunotherapy by the sublingual route for respiratory allergy.

@en

P2093

Franco Frati

http://www.w3.org/2001/XMLSchema#string

Patrizia Berto

http://www.w3.org/2001/XMLSchema#string

Silvia Scurati

http://www.w3.org/2001/XMLSchema#string

Simonetta Masieri

http://www.w3.org/2001/XMLSchema#string

P2860

Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee

Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method.

Safety of sublingual-swallow immunotherapy in children and adults.

Allergic rhinitis and its impact on asthma.

Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials.

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper.

The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis.

Noninjection routes for immunotherapy.

P2888

P304

29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1710-1492-6-29

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Cristoforo Incorvaia

P577

2010-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47728927

http://www.w3.org/2001/XMLSchema#string

P6179

1001151499

http://www.w3.org/2001/XMLSchema#string

P698

21062481

http://www.w3.org/2001/XMLSchema#string

P921

P932

2992485

http://www.w3.org/2001/XMLSchema#string